If you only skim one chart in the GMC’s Workforce report 2025, make it the one about what happens after international doctors register.

The headline isn’t just that the UK remains dependent on international medical graduates. 

It’s that the path from registration to employment looks meaningfully tougher for some routes in 2024 than it did even two years ago.  

 

Key takeaways 

• The number of nonUK primary medical qualification (PMQ) doctors taking up a licence plateaued in 2024: 20,060 in 2024 vs 19,629 in 2023 (Part 1, p6). 

• For IMG PLAB joiners (a route without guaranteed employment), only 13% of the 2024 cohort had a designated body (DB) connection within six months, vs 26% for 2021 and 2022 cohorts (p8). 

• “Leavers” rose sharply in 2024, but a significant portion is explained by administrative catch-up affecting doctors who never worked here (p9). 

• More worrying for workforce capacity: nonUK PMQ leavers who had a DB connection increased to 4,880 in 2024 (up 26%) (p9). 

• Headcount is still growing overall, but the report itself emphasises headcount isn’t the same as clinical capacity (Box 1, p23). 

 

The UK’s international dependence remains, but the shape is changing 

The report’s foreword doesn’t hedge. International doctors have been “central to UK health services” since the NHS began, and internationally trained doctors now make up a large share of the licensed workforce (Foreword, p2–3). That framing matters because it prevents the most common misread: that any slowing in international joiners implies the UK can now “go it alone.” 

The workforce still grows, and nonUK joiners remain high. But the trendline changed in 2024. The number of nonUK PMQ doctors taking up a licence was essentially flat compared with 2023 (p6). Flat isn’t collapse, but it is a break in direction after years of sharp rises (excluding the pandemic year). 

From a planning perspective, you don’t need the flow to collapse for risk to appear. You just need it to slow while demand and service reliance remain structurally high. 

 

The most important data point isn’t registration, it’s what happens next 

The report offers a useful distinction that policy debates often skip: not all routes into UK registration are equivalent. 

• IMG sponsorship implies employer support for a defined role. 

• IMG PLAB is more speculative: many doctors take up registration without a job offer in hand (p8). 

That matters because “UK is still recruiting doctors” can be true at the top of the funnel, while “doctors are struggling to secure work” is true at the point of landing. 

And that’s where the report drops a clear warning signal: among IMG PLAB joiners, the share connecting to a designated body (DB) within six months fell dramatically for the 2024 cohort: 13% (p8). For context, the 2021 and 2022 cohorts both showed 26% at six months. 

A DB connection isn’t a perfect employment measure, but the report describes it as a strong indication a doctor has found work (p8). It’s one of the best administrative “traces” available at UK scale. 

A critical note: DB connection is a proxy, but a meaningful one 

You should treat the sixmonth DB metric as an early indicator, not a verdict. It may partly reflect: 

• onboarding delays 

• contract start dates 

• revalidation/admin lags 

• time spent in observerships or informal clinical exposure 

But proxies become powerful when they move sharply. A drop from roughly oneinfour to roughly oneineight is not a rounding error. It’s a directional shift. 

 

Leavers rose in 2024 and the report shows what’s “real” vs “noise” 

The report is unusually explicit about interpretability: it cautions that one big driver of 2024 leavers is linked to a resumed GMC process (paused during the pandemic) to withdraw licences for reasons like nonpayment of fees (p9). That process mainly affects nonUK PMQ doctors who never connected to a DB and therefore are unlikely to have worked in the UK (p9). 

This is good analysis. It’s the report telling you: don’t turn an administrative cleanup into a workforce panic. 

But then it makes a second point that does matter for workforce capacity: the number of leavers who had previously connected to a DB increased for both UK and nonUK groups (p9). For nonUK PMQ doctors with DB connection, leavers grew 26% to 4,880 in 2024 (p9). UK PMQ DBconnected leavers rose too, though less sharply (p9). 

The report adds a further check: once you account for the growing population, the proportion of licensed and DBconnected doctors leaving rises only modestly, from 3.2% in 2023 to 3.6% in 2024 (p9). That’s a useful brake on sensationalism. 

So what’s the right read? 

The right read is: volatility is rising at the margin 

• A modest increase in the rate of leaving can still be a big operational problem if the workforce is stretched and unevenly distributed. 

• The distribution matters: if leaving concentrates in shortage specialties, deprived geographies, or nontraining service roles, the impact is outsized. 

 

What could explain a tightening market for new international joiners? 

The report doesn’t diagnose root causes in depth, it flags the trend and argues for transparency and fairness (p10). But we can responsibly outline plausible contributors without overclaiming: 

1. Trust recruitment freezes or tightened approvals
   Even a “soft freeze” can push job starts out by months, which would show up in the sixmonth DB metric. 
2. Supervision and rota capacity constraints
   Hospitals may need doctors, but still struggle to onboard safely without supervision bandwidth. 
3. Mismatch between where doctors are and where jobs are
   Many international joiners cluster in a few cities or regions, while vacancies may sit elsewhere. 
4. Competition intensifying in nontraining roles
   If more doctors are in locally employed roles (Part 2 digs into this), competition for the next rung grows. 

The report’s key point is not which of these dominates, it’s that doctors making highstakes migration decisions deserve evidence about the range of outcomes (Foreword p2; p10). 

 

Why this matters to policy: rhetoric and incentives shape migration flows 

The foreword gives an important warning: doctors are mobile, global demand is high, and perceived lack of progression or support can push talent elsewhere (p3). This isn’t abstract. If policy debates harden around “prioritising” one group without recognising workforce reliance, the UK risks: 

• reducing future inflows 

• accelerating outflows 

• and damaging trust in the system’s fairness 

None of that requires bad intent. It can happen through signals: uncertainty, delays, opaque recruitment processes, and weak pastoral support. 

 

What should leaders do next? 

If you run a trust, a system, or a workforce programme, the action isn’t to “turn off” international recruitment. It’s to make the pathway from registration to safe employment: 

• more predictable, 

• more transparent, 

• and less financially and psychologically risky. 

Three practical moves: 

1. Publish realistic timelines from offer → start date → DB connection → first appraisal. 
2. Create structured onboarding and buddying for doctors new to UK practice. 
3. Track outcomes (time to first substantive role; retention at 12 and 24 months) and share them openly. 

A tightening market isn’t just an economic issue. In healthcare, it’s a safety and fairness issue for doctors and patients.  

Primary source: GMC Workforce report 2025